XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Class A Common Stock
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Series A Preferred Stock
Series B Preferred Stock
Class A Common Stock
Total
Beginning Balance (in shares) at Dec. 31, 2020             4,950,129  
Beginning Balance at Dec. 31, 2020 $ 4,950 $ 3,251,240   $ (25,737,640)       $ (22,481,450)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense   182,225           182,225
Net loss       (6,229,651)       (6,229,651)
Ending Balance at Mar. 31, 2021 4,950 3,433,465   (31,967,291)       (28,528,876)
Ending Balance (in shares) at Mar. 31, 2021             4,950,129  
Beginning Balance at Dec. 31, 2020         $ 21,119,940 $ 36,983,910   58,103,850
Beginning Balance (in shares) at Dec. 31, 2020         2,495,933 3,619,292    
Ending Balance at Mar. 31, 2021         $ 21,119,940 $ 36,983,910   58,103,850
Ending Balance (in shares) at Mar. 31, 2021         2,495,933 3,619,292    
Beginning Balance (in shares) at Dec. 31, 2021             26,320,199  
Beginning Balance at Dec. 31, 2021 26,320 215,276,186 $ (49,009) (59,273,388)       155,980,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options 63 193,048           $ 193,111
Issuance of common stock upon exercise of stock options (in shares)             63,100 63,100
Stock-based compensation expense   897,650           $ 897,650
Net loss       (12,896,374)       (12,896,374)
Other comprehensive loss     (118,386)         (118,386)
Ending Balance at Mar. 31, 2022 $ 26,383 $ 216,366,884 $ (167,395) $ (72,169,762)       $ 144,056,110
Ending Balance (in shares) at Mar. 31, 2022             26,383,299